• Multiple Myeloma
• Myelodysplastic Syndrome

For Azra Borogovac, M.D., M.S., the patient is the most important part of the medical team. She sees the opportunity to provide care to people with cancer as a privilege. In her mind, there is no one-size-fits-all treatment plan. Rather, she sees each patient as a whole person with their own unique priorities and circumstances that must be considered.

Dr. Borogovac pursued her training as a physician at the University of Massachusetts Medical School, where she also trained as a resident in internal medicine. She was a fellow in hematology/oncology and stem cell transplant and cellular therapy at the University of Oklahoma Health Sciences Center, later adding an M.S. in clinical and translational science there as well. In addition, she also completed a highly competitive yearlong program at the American Society of Hematology Clinical Translational Research Institute.

A researcher seeking to improve treatment for blood cancers and ameliorate side effects, she leads clinical trials into protocols for targeted drugs, cellular therapies and blood stem cell transplants. Before joining City of Hope in 2022, she was an assistant professor of hematology/oncology at the University of Oklahoma’s Stephenson Cancer Center.

Dr. Borogovac is fluent in Bosnian. In her free time, she likes to spend time with her daughter, hike, travel and explore new restaurants.